[Clinical evaluation of serum CEA levels in uterine cervix cancer].
Serum CEA levels were measured in the blood of 98 patients with uterine cervix cancer before, during, and after treatment to investigate the relationship among the CEA level, the extent of the disease, and recovery. The CEA level rose as the disease progressed. Although there was no significant difference in the survival rates of patients with various CEA levels, those who returned to normal levels after treatment recuperated better. There was not clear evidence that CEA levels are clinically significant. However, it can be concluded that CEA levels at pre- and post-treatment times are helpful in the early detection of disease, prognosis, and in predicting recurrence or metastasis.
D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000276:immunology; D011379:Prognosis; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000473:pathology / Q000532:radiotherapy
D002272:Carcinoembryonic Antigen